Zobrazeno 1 - 10
of 83
pro vyhledávání: '"domenico angelucci"'
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer
Autor:
Emanuela Guerra, Marco Trerotola, Valeria Relli, Rossano Lattanzio, Romina Tripaldi, Giovanna Vacca, Martina Ceci, Khouloud Boujnah, Valeria Garbo, Antonino Moschella, Romina Zappacosta, Pasquale Simeone, Robert de Lange, Ulrich H. Weidle, Maria Teresa Rotelli, Arcangelo Picciariello, Raffaella Depalo, Patrizia Querzoli, Massimo Pedriali, Enzo Bianchini, Domenico Angelucci, Giuseppe Pizzicannella, Carla Di Loreto, Mauro Piantelli, Laura Antolini, Xiao-Feng Sun, Donato F. Altomare, Saverio Alberti
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 9, Pp 898-911 (2021)
We recently reported that activation of Trop-2 through its cleavage at R87-T88 by ADAM10 underlies Trop-2–driven progression of colon cancer. However, the mechanism of action and pathological impact of Trop-2 in metastatic diffusion remain unexplor
Externí odkaz:
https://doaj.org/article/47c452d30d02427780fceca7aeda7338
Autor:
Francesco Cognetti, Riccardo Masetti, Alessandra Fabi, Giulia Bianchi, Donatella Santini, Alessia Rognone, Giovanna Catania, Domenico Angelucci, Giuseppe Naso, Mario Giuliano, Lucia Vassalli, Patrizia Vici, Giovanni Scognamiglio, Daniele Generali, Alberto Zambelli, Marco Colleoni, Corrado Tinterri, Francesco Scanzi, Leonardo Vigna, Paola Scavina, Teresa Gamucci, Emilia Marrazzo, Angelo Fedele Scinto, Rossana Berardi, Maria Agnese Fabbri, Graziella Pinotti, Daniela Franco, Daniela Andreina Terribile, Giuseppe Tonini, Daniela Cianniello, Sandro Barni
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Clinicopathological prognostic features have limited value to identify with precision newly diagnosed patients with hormone receptor (HR)-positive, HER2-negative breast cancer (BC), who would benefit from chemotherapy (CT) in addition to adj
Externí odkaz:
https://doaj.org/article/a0a882fd09a64018b374c4f2f70cd885
Autor:
Anna Di Benedetto, Cristiana Ercolani, Laura Pizzuti, Domenico Angelucci, Domenico Sergi, Camilla Marinelli, Laura Iezzi, Francesca Sperati, Irene Terrenato, Marco Mazzotta, Luciano Mariani, Enrico Vizza, Giancarlo Paoletti, Silverio Tomao, Marcello Maugeri-Saccà, Maddalena Barba, Nicola Tinari, Clara Natoli, Gennaro Ciliberto, Antonino Grassadonia, Patrizia Vici
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: The logic behind the outcome of endocrine therapy in breast cancer has long remained poorly understood. The prognostic role of DNA damage and repair biomarkers (DDR) was explored in postmenopausal, hormone-receptor-positive breast cancer
Externí odkaz:
https://doaj.org/article/eaa712645f8543eb90db2158fbdff191
Autor:
Emma Di Carlo, Clara Natoli, Laura Iezzi, Maria Bertolotto, Domenico Ribatti, Silvia Esposito, Lamberto Manzoli, Serena Di Meo, Domenico Angelucci, Carlo Sorrentino, Claudia Cocco, Irma Airoldi
The inflammatory tissue microenvironment that promotes the development of breast cancer is not fully understood. Here we report a role for elevated IL30 in supporting the breast cancer cell viability and invasive migration. IL30 was absent in normal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::727680bd4b43af0e29170c341ab756d3
https://doi.org/10.1158/0008-5472.c.6508706.v1
https://doi.org/10.1158/0008-5472.c.6508706.v1
Autor:
Emma Di Carlo, Clara Natoli, Laura Iezzi, Maria Bertolotto, Domenico Ribatti, Silvia Esposito, Lamberto Manzoli, Serena Di Meo, Domenico Angelucci, Carlo Sorrentino, Claudia Cocco, Irma Airoldi
Supplementary Table S1. Antibodies used in immunostaining. Supplementary Table S2. Characteristics and outcomes by levels of IL-30 expression in tumor cells (primary tumor). Supplementary Table S3. Characteristics and outcomes by levels of IL-30 expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29385837046024b93bdfb4ccd9684330
https://doi.org/10.1158/0008-5472.22413419
https://doi.org/10.1158/0008-5472.22413419
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
MRI-Based Radiomics Approach Predicts Tumor Recurrence in ER + /HER2 − Early Breast Cancer Patients.
Autor:
Chiacchiaretta, Piero, Mastrodicasa, Domenico, Chiarelli, Antonio Maria, Luberti, Riccardo, Croce, Pierpaolo, Sguera, Mario, Torrione, Concetta, Marinelli, Camilla, Marchetti, Chiara, Domenico, Angelucci, Cocco, Giulio, Di Credico, Angela, Russo, Alessandro, D'Eramo, Claudia, Corvino, Antonio, Colasurdo, Marco, Sensi, Stefano L., Muzi, Marzia, Caulo, Massimo, Delli Pizzi, Andrea
Publikováno v:
Journal of Digital Imaging; Jun2023, Vol. 36 Issue 3, p1071-1080, 10p, 2 Diagrams, 2 Charts, 2 Graphs
Autor:
Giulio, Gualdi, Fabrizio, Panarese, Giovanna, Meogrossi, Michele, Marchioni, Michele, De Tursi, Pietro, Di Marino, Domenico, Angelucci, Massimo, Amatetti, Gianluca, Proietto, Marta, Di Nicola, Paolo, Amerio, Roberta, Cianci
Publikováno v:
Pigment Cell & Melanoma Research. 33:709-718
Melanomas are skin tumors that show a variety of biological behavior. Some develop very fast and some other grow extremely slow, with metastasis appearing, eventually, many years after the diagnosis. The number of mitoses in primary melanoma has been
Autor:
Antonella Colasante, Monica Di Tommaso, Giulia Sindici, F. Perrotti, Antonietta Augurio, Giuseppe Pizzicannella, Domenico Angelucci, Pierluigi Di Sebastiano, Nicola Di Bartolomeo, Marta Di Nicola, Massimo Basti, V. Borzillo, Paolo Innocenti, Maria Taraborrelli, Luciana Caravatta, Michele Marchioni, Consuelo Rosa, Domenico Genovesi, Roberta Cianci, Sara Di Santo, Lorenzo Mazzola
Publikováno v:
In Vivo
Aim Pathological complete response (pCR) and clinical outcomes [overall survival (OS), disease-free survival (DFS), locoregional control (LC)] were evaluated in a single-institution experience of different schedules of neoadjuvant chemoradiotherapy (
Autor:
Lucia Anna Ursini, Marianna Nuzzo, Consuelo Rosa, Marzia Borgia, Luciana Caravatta, Monica Di Tommaso, Marianna Trignani, Fiorella Cristina Di Guglielmo, Giampiero Ausili Cefaro, Domenico Angelucci, Marzia Muzi, Gianluigi Martino, Ettore Cianchetti, Simona Grossi, Saveria Tavoletta, Davide Brocco, Antonino Grassadonia, Nicola Tinari, Simona Gildetti, Nicola D’Ostilio, Liborio Stuppia, Annamaria Porreca, Marta Di Nicola, Domenico Genovesi
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 198(7)
Purpose Axillary management remains unclear when sentinel lymph node (SLN) results are positive in cN0 patients with breast cancer (BC). The trial ACOSOG Z0011 represented a revolution with axillary lymph node dissection (ALND) omission in SLN+ patie